BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Goncharov T, Hedayati S, Mulvihill MM, Izrael-tomasevic A, Zobel K, Jeet S, Fedorova AV, Eidenschenk C, deVoss J, Yu K, Shaw AS, Kirkpatrick DS, Fairbrother WJ, Deshayes K, Vucic D. Disruption of XIAP-RIP2 Association Blocks NOD2-Mediated Inflammatory Signaling. Molecular Cell 2018;69:551-565.e7. [DOI: 10.1016/j.molcel.2018.01.016] [Cited by in Crossref: 45] [Cited by in F6Publishing: 46] [Article Influence: 11.3] [Reference Citation Analysis]
Number Citing Articles
1 Ma X, Qiu Y, Sun Y, Zhu L, Zhao Y, Li T, Lin Y, Ma D, Qin Z, Sun C, Han L. NOD2 inhibits tumorigenesis and increases chemosensitivity of hepatocellular carcinoma by targeting AMPK pathway. Cell Death Dis 2020;11:174. [PMID: 32144252 DOI: 10.1038/s41419-020-2368-5] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 5.0] [Reference Citation Analysis]
2 Polykretis P, Luchinat E, Bonucci A, Giachetti A, Graewert MA, Svergun DI, Banci L. Conformational characterization of full-length X-chromosome-linked inhibitor of apoptosis protein (XIAP) through an integrated approach. IUCrJ 2019;6:948-57. [PMID: 31576227 DOI: 10.1107/S205225251901073X] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
3 Arnold DE, Nofal R, Wakefield C, Lehmberg K, Wustrau K, Albert MH, Morris EC, Heimall JR, Bunin NJ, Kumar A, Jordan MB, Cole T, Choo S, Brettig T, Speckmann C, Ehl S, Salamonowicz M, Wahlstrom J, Rao K, Booth C, Worth A, Marsh RA. Reduced-Intensity/Reduced-Toxicity Conditioning Approaches Are Tolerated in XIAP Deficiency but Patients Fare Poorly with Acute GVHD. J Clin Immunol 2021. [PMID: 34586554 DOI: 10.1007/s10875-021-01103-6] [Reference Citation Analysis]
4 Pellegrini E, Desfosses A, Wallmann A, Schulze WM, Rehbein K, Mas P, Signor L, Gaudon S, Zenkeviciute G, Hons M, Malet H, Gutsche I, Sachse C, Schoehn G, Oschkinat H, Cusack S. RIP2 filament formation is required for NOD2 dependent NF-κB signalling. Nat Commun 2018;9:4043. [PMID: 30279485 DOI: 10.1038/s41467-018-06451-3] [Cited by in Crossref: 33] [Cited by in F6Publishing: 28] [Article Influence: 8.3] [Reference Citation Analysis]
5 Martínez-Torres RJ, Chamaillard M. The Ubiquitin Code of NODs Signaling Pathways in Health and Disease. Front Immunol 2019;10:2648. [PMID: 31803185 DOI: 10.3389/fimmu.2019.02648] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
6 Honjo H, Watanabe T, Kamata K, Minaga K, Kudo M. RIPK2 as a New Therapeutic Target in Inflammatory Bowel Diseases. Front Pharmacol 2021;12:650403. [PMID: 33935757 DOI: 10.3389/fphar.2021.650403] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
7 Miller MH, Shehat MG, Tigno-Aranjuez JT. Immune Modulation of Allergic Asthma by Early Pharmacological Inhibition of RIP2. Immunohorizons 2020;4:825-36. [PMID: 33443037 DOI: 10.4049/immunohorizons.2000073] [Reference Citation Analysis]
8 Suebsuwong C, Dai B, Pinkas DM, Duddupudi AL, Li L, Bufton JC, Schlicher L, Gyrd-Hansen M, Hu M, Bullock AN, Degterev A, Cuny GD. Receptor-interacting protein kinase 2 (RIPK2) and nucleotide-binding oligomerization domain (NOD) cell signaling inhibitors based on a 3,5-diphenyl-2-aminopyridine scaffold. Eur J Med Chem 2020;200:112417. [PMID: 32505849 DOI: 10.1016/j.ejmech.2020.112417] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
9 Schiffmann LM, Göbel H, Löser H, Schorn F, Werthenbach JP, Fuchs HF, Plum PS, Bludau M, Zander T, Schröder W, Bruns CJ, Kashkar H, Quaas A, Gebauer F. Elevated X-linked inhibitor of apoptosis protein (XIAP) expression uncovers detrimental prognosis in subgroups of neoadjuvant treated and T-cell rich esophageal adenocarcinoma. BMC Cancer 2019;19:531. [PMID: 31151416 DOI: 10.1186/s12885-019-5722-1] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
10 Jensen S, Seidelin JB, LaCasse EC, Nielsen OH. SMAC mimetics and RIPK inhibitors as therapeutics for chronic inflammatory diseases. Sci Signal. 2020;13. [PMID: 32071170 DOI: 10.1126/scisignal.aax8295] [Cited by in Crossref: 18] [Cited by in F6Publishing: 19] [Article Influence: 9.0] [Reference Citation Analysis]
11 Lalaoui N, Vaux DL. Recent advances in understanding inhibitor of apoptosis proteins. F1000Res 2018;7:F1000 Faculty Rev-1889. [PMID: 30631429 DOI: 10.12688/f1000research.16439.1] [Cited by in Crossref: 37] [Cited by in F6Publishing: 31] [Article Influence: 9.3] [Reference Citation Analysis]
12 Ellwanger K, Briese S, Arnold C, Kienes I, Heim V, Nachbur U, Kufer TA. XIAP controls RIPK2 signaling by preventing its deposition in speck-like structures. Life Sci Alliance 2019;2:e201900346. [PMID: 31350258 DOI: 10.26508/lsa.201900346] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.7] [Reference Citation Analysis]
13 Cossu F, Milani M, Mastrangelo E, Lecis D. Targeting the BIR Domains of Inhibitor of Apoptosis (IAP) Proteins in Cancer Treatment. Comput Struct Biotechnol J 2019;17:142-50. [PMID: 30766663 DOI: 10.1016/j.csbj.2019.01.009] [Cited by in Crossref: 25] [Cited by in F6Publishing: 22] [Article Influence: 8.3] [Reference Citation Analysis]
14 Jost PJ, Vucic D. Regulation of Cell Death and Immunity by XIAP. Cold Spring Harb Perspect Biol 2020;12:a036426. [PMID: 31843992 DOI: 10.1101/cshperspect.a036426] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
15 Liu M, Chen H, Chen X, Xiong J, Song Z. Silencing UCHL3 enhances radio-sensitivity of non-small cell lung cancer cells by inhibiting DNA repair. Aging (Albany NY) 2021;13:14277-88. [PMID: 34016790 DOI: 10.18632/aging.203043] [Reference Citation Analysis]
16 Li ZQ, Chen X, Wang Y. Small molecules targeting ubiquitination to control inflammatory diseases. Drug Discov Today 2021:S1359-6446(21)00216-6. [PMID: 33992766 DOI: 10.1016/j.drudis.2021.04.029] [Reference Citation Analysis]
17 Kekessie I, Goncharov T, Kőműves LG, Vucic D, Song A. A solid-phase approach for the synthesis of muramyl dipeptide conjugates for detection of NOD2. Bioorg Chem 2021;116:105360. [PMID: 34562676 DOI: 10.1016/j.bioorg.2021.105360] [Reference Citation Analysis]
18 Lim J, Park H, Heisler J, Maculins T, Roose-Girma M, Xu M, Mckenzie B, van Lookeren Campagne M, Newton K, Murthy A. Autophagy regulates inflammatory programmed cell death via turnover of RHIM-domain proteins. Elife 2019;8:e44452. [PMID: 31287416 DOI: 10.7554/eLife.44452] [Cited by in Crossref: 28] [Cited by in F6Publishing: 22] [Article Influence: 9.3] [Reference Citation Analysis]
19 Bergmann C, Hallenberger L, Chenguiti Fakhouri S, Merlevede B, Brandt A, Dees C, Zhu H, Zehender A, Zhou X, Schwab A, Chen CW, Györfi AH, Matei AE, Chakraborty D, Trinh-Minh T, Rauber S, Coras R, Bozec A, Kreuter A, Ziemer M, Schett G, Distler JHW. X-linked inhibitor of apoptosis protein (XIAP) inhibition in systemic sclerosis (SSc). Ann Rheum Dis 2021:annrheumdis-2020-219822. [PMID: 33903093 DOI: 10.1136/annrheumdis-2020-219822] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
20 Vucic D. XIAP at the crossroads of cell death and inflammation. Oncotarget 2018;9:27319-20. [PMID: 29937987 DOI: 10.18632/oncotarget.25363] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
21 Haile PA, Casillas LN, Bury MJ, Mehlmann JF, Singhaus R, Charnley AK, Hughes TV, Demartino MP, Wang GZ, Romano JJ, Dong X, Plotnikov NV, Lakdawala AS, Convery MA, Votta BJ, Lipshutz DB, Desai BM, Swift B, Capriotti CA, Berger SB, Mahajan MK, Reilly MA, Rivera EJ, Sun HH, Nagilla R, Lepage C, Ouellette MT, Totoritis RD, Donovan BT, Brown BS, Chaudhary KW, Gough PJ, Bertin J, Marquis RW. Identification of Quinoline-Based RIP2 Kinase Inhibitors with an Improved Therapeutic Index to the hERG Ion Channel. ACS Med Chem Lett 2018;9:1039-44. [DOI: 10.1021/acsmedchemlett.8b00344] [Cited by in Crossref: 18] [Cited by in F6Publishing: 15] [Article Influence: 4.5] [Reference Citation Analysis]
22 Shehat MG, Cardona OA, Aranjuez GF, Jewett MW, Tigno-Aranjuez JT. RIP2 promotes FcγR-mediated reactive oxygen species production. J Biol Chem 2019;294:10365-78. [PMID: 31113864 DOI: 10.1074/jbc.RA118.007218] [Cited by in Crossref: 2] [Article Influence: 0.7] [Reference Citation Analysis]
23 den Besten W, Verma K, Yamazoe S, Blaquiere N, Phung W, Izrael-Tomasevic A, Mulvihill MM, Helgason E, Prakash S, Goncharov T, Vucic D, Dueber E, Fairbrother WJ, Wertz I, Yu K, Staben ST. Primary Amine Tethered Small Molecules Promote the Degradation of X-Linked Inhibitor of Apoptosis Protein. J Am Chem Soc 2021;143:10571-5. [PMID: 34236858 DOI: 10.1021/jacs.1c05269] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
24 Huang CS, Oberbeck N, Hsiao YC, Liu P, Johnson AR, Dixit VM, Hymowitz SG. Crystal Structure of Ripk4 Reveals Dimerization-Dependent Kinase Activity. Structure 2018;26:767-777.e5. [PMID: 29706531 DOI: 10.1016/j.str.2018.04.002] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
25 Zarrin AA, Bao K, Lupardus P, Vucic D. Kinase inhibition in autoimmunity and inflammation. Nat Rev Drug Discov 2021;20:39-63. [PMID: 33077936 DOI: 10.1038/s41573-020-0082-8] [Cited by in Crossref: 30] [Cited by in F6Publishing: 27] [Article Influence: 15.0] [Reference Citation Analysis]
26 Varfolomeev E, Goncharov T, Vucic D. Immunoblot Analysis of the Regulation of TNF Receptor Family-Induced NF-κB Signaling by c-IAP Proteins. Methods Mol Biol 2021;2366:109-23. [PMID: 34236635 DOI: 10.1007/978-1-0716-1669-7_7] [Reference Citation Analysis]
27 Heim VJ, Stafford CA, Nachbur U. NOD Signaling and Cell Death. Front Cell Dev Biol 2019;7:208. [PMID: 31632962 DOI: 10.3389/fcell.2019.00208] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 4.7] [Reference Citation Analysis]
28 He S, Wang X. RIP kinases as modulators of inflammation and immunity. Nat Immunol 2018;19:912-22. [DOI: 10.1038/s41590-018-0188-x] [Cited by in Crossref: 61] [Cited by in F6Publishing: 62] [Article Influence: 15.3] [Reference Citation Analysis]
29 Xia S, Fu TM, Wu H. Inflammation NODs to Antagonists of RIP2-XIAP Interaction. Mol Cell 2018;69:535-6. [PMID: 29452633 DOI: 10.1016/j.molcel.2018.02.003] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
30 Hofmann SR, Girschick L, Stein R, Schulze F. Immune modulating effects of receptor interacting protein 2 (RIP2) in autoinflammation and immunity. Clin Immunol 2021;223:108648. [PMID: 33310070 DOI: 10.1016/j.clim.2020.108648] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
31 Cuny GD, Degterev A. RIPK protein kinase family: Atypical lives of typical kinases. Semin Cell Dev Biol 2021;109:96-105. [PMID: 32732131 DOI: 10.1016/j.semcdb.2020.06.014] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
32 Ieong C, Yang H, Ma J, Lai W. Prognostic significance of X-linked inhibitor of apoptosis protein in patients with gastrointestinal tract cancers: A meta-analysis. Medicine (Baltimore) 2020;99:e18497. [PMID: 32118702 DOI: 10.1097/MD.0000000000018497] [Reference Citation Analysis]
33 Topal Y, Gyrd-hansen M. RIPK2 NODs to XIAP and IBD. Seminars in Cell & Developmental Biology 2021;109:144-50. [DOI: 10.1016/j.semcdb.2020.07.001] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 4.0] [Reference Citation Analysis]
34 Haffner CD, Charnley AK, Aquino CJ, Casillas L, Convery MA, Cox JA, Elban MA, Goodwin NC, Gough PJ, Haile PA, Hughes TV, Knapp-Reed B, Kreatsoulas C, Lakdawala AS, Li H, Lian Y, Lipshutz D, Mehlmann JF, Ouellette M, Romano J, Shewchuk L, Shu A, Votta BJ, Zhou H, Bertin J, Marquis RW. Discovery of Pyrazolocarboxamides as Potent and Selective Receptor Interacting Protein 2 (RIP2) Kinase Inhibitors. ACS Med Chem Lett 2019;10:1518-23. [PMID: 31749904 DOI: 10.1021/acsmedchemlett.9b00141] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
35 Kulkarni M, Stolp ZD, Hardwick JM. Targeting intrinsic cell death pathways to control fungal pathogens. Biochem Pharmacol 2019;162:71-8. [PMID: 30660496 DOI: 10.1016/j.bcp.2019.01.012] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 2.3] [Reference Citation Analysis]
36 Strigli A, Gopalakrishnan S, Zeissig Y, Basic M, Wang J, Schwerd T, Doms S, Peuker K, Hartwig J, Harder J, Hönscheid P, Arnold P, Kurth T, Rost F, Petersen BS, Forster M, Franke A, Kelsen JR, Rohlfs M, Klein C, Muise AM, Warner N, Nambu R, Mayerle J, Török HP, Linkermann A, Muders MH, Baretton GB, Hampe J, Aust DE, Baines JF, Bleich A, Zeissig S. Deficiency in X-linked inhibitor of apoptosis protein promotes susceptibility to microbial triggers of intestinal inflammation. Sci Immunol 2021;6:eabf7473. [PMID: 34739342 DOI: 10.1126/sciimmunol.abf7473] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
37 Dumétier B, Zadoroznyj A, Dubrez L. IAP-Mediated Protein Ubiquitination in Regulating Cell Signaling. Cells 2020;9:E1118. [PMID: 32365919 DOI: 10.3390/cells9051118] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
38 Pan D, Lyu Y, Zhang N, Wang X, Lei T, Liang Z. RIP2 knockdown inhibits cartilage degradation and oxidative stress in IL-1β-treated chondrocytes via regulating TRAF3 and inhibiting p38 MAPK pathway. Clin Immunol 2021;232:108868. [PMID: 34587513 DOI: 10.1016/j.clim.2021.108868] [Reference Citation Analysis]
39 Heim VJ, Dagley LF, Stafford CA, Hansen FM, Clayer E, Bankovacki A, Webb AI, Lucet IS, Silke J, Nachbur U. A regulatory region on RIPK2 is required for XIAP binding and NOD signaling activity. EMBO Rep 2020;21:e50400. [PMID: 32954645 DOI: 10.15252/embr.202050400] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
40 Hrdinka M, Schlicher L, Dai B, Pinkas DM, Bufton JC, Picaud S, Ward JA, Rogers C, Suebsuwong C, Nikhar S, Cuny GD, Huber KV, Filippakopoulos P, Bullock AN, Degterev A, Gyrd-Hansen M. Small molecule inhibitors reveal an indispensable scaffolding role of RIPK2 in NOD2 signaling. EMBO J 2018;37:e99372. [PMID: 30026309 DOI: 10.15252/embj.201899372] [Cited by in Crossref: 31] [Cited by in F6Publishing: 29] [Article Influence: 7.8] [Reference Citation Analysis]
41 Liu W, Zhao WJ, Wu YH. Study on the differentially expressed genes and signaling pathways in dermatomyositis using integrated bioinformatics method. Medicine (Baltimore) 2020;99:e21863. [PMID: 32846838 DOI: 10.1097/MD.0000000000021863] [Reference Citation Analysis]
42 Steinle H, Ellwanger K, Mirza N, Briese S, Kienes I, Pfannstiel J, Kufer TA. 14-3-3 and erlin proteins differentially interact with RIPK2 complexes. J Cell Sci 2021;134:jcs258137. [PMID: 34152391 DOI: 10.1242/jcs.258137] [Reference Citation Analysis]
43 Beck DB, Werner A, Kastner DL, Aksentijevich I. Disorders of ubiquitylation: unchained inflammation. Nat Rev Rheumatol 2022. [PMID: 35523963 DOI: 10.1038/s41584-022-00778-4] [Reference Citation Analysis]
44 Kapplusch F, Schulze F, Reinke S, Russ S, Linge M, Kulling F, Kriechling F, Höhne K, Winkler S, Hartmann H, Rösen-wolff A, Anastassiadis K, Hedrich CM, Hofmann SR. RIP2-deficiency induces inflammation in response to SV40 Large T induced genotoxic stress through altered ROS homeostasis. Clinical Immunology 2022. [DOI: 10.1016/j.clim.2022.108998] [Reference Citation Analysis]
45 Cockram PE, Kist M, Prakash S, Chen SH, Wertz IE, Vucic D. Ubiquitination in the regulation of inflammatory cell death and cancer. Cell Death Differ 2021;28:591-605. [PMID: 33432113 DOI: 10.1038/s41418-020-00708-5] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
46 Liao Y, Zhao J, Bulek K, Tang F, Chen X, Cai G, Jia S, Fox PL, Huang E, Pizarro TT, Kalady MF, Jackson MW, Bao S, Sen GC, Stark GR, Chang CJ, Li X. Inflammation mobilizes copper metabolism to promote colon tumorigenesis via an IL-17-STEAP4-XIAP axis. Nat Commun 2020;11:900. [PMID: 32060280 DOI: 10.1038/s41467-020-14698-y] [Cited by in Crossref: 14] [Cited by in F6Publishing: 17] [Article Influence: 7.0] [Reference Citation Analysis]
47 Ku CL, Chen IT, Lai MZ. Infection-induced inflammation from specific inborn errors of immunity to COVID-19. FEBS J 2021;288:5021-41. [PMID: 33971084 DOI: 10.1111/febs.15961] [Reference Citation Analysis]
48 Roudaire T, Héloir MC, Wendehenne D, Zadoroznyj A, Dubrez L, Poinssot B. Cross Kingdom Immunity: The Role of Immune Receptors and Downstream Signaling in Animal and Plant Cell Death. Front Immunol 2020;11:612452. [PMID: 33763054 DOI: 10.3389/fimmu.2020.612452] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
49 Hart AC, Abell L, Guo J, Mertzman ME, Padmanabha R, Macor JE, Chaudhry C, Lu H, O'Malley K, Shaw PJ, Weigelt C, Pokross M, Kish K, Kim KS, Cornelius L, Douglas AE, Calambur D, Zhang P, Carpenter B, Pitts WJ. Identification of RIPK3 Type II Inhibitors Using High-Throughput Mechanistic Studies in Hit Triage. ACS Med Chem Lett 2020;11:266-71. [PMID: 32184955 DOI: 10.1021/acsmedchemlett.9b00065] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 6.5] [Reference Citation Analysis]
50 Zou M, Zeng QS, Nie J, Yang JH, Luo ZY, Gan HT. The Role of E3 Ubiquitin Ligases and Deubiquitinases in Inflammatory Bowel Disease: Friend or Foe? Front Immunol 2021;12:769167. [PMID: 34956195 DOI: 10.3389/fimmu.2021.769167] [Reference Citation Analysis]